Caption Management’s Veracyte VCYT Stock Holding History

Caption Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-129,500	Closed	-$5.45M	–	2097
2025 Q4	$5.45M	Buy	+129,500	New	+$5.22M	0.04%	494

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Caption Management's VCYT Position: Q1 2025 in Review

Caption Management sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 9,500 shares — an estimated $376K sold.

Caption Management first reported a position in VCYT in Q4 2024 and held it in 1 quarter. The position peaked at $376K in Q4 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

Caption Management reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
Caption Management sold 9,500 Veracyte shares in Q1 2025, an estimated $376K.
Caption Management first reported a position in Veracyte in Q4 2024 and held it in 1 quarter.
Caption Management's Veracyte position peaked at $376K in Q4 2024.
287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Caption Management's 13F filing for Q1 2025, filed 15 May 2025.